{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:15:38Z","timestamp":1787062538555,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jaci.2020.08.007","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T19:01:07Z","timestamp":1597518067000},"page":"1269-1280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease"],"prefix":"10.1016","volume":"147","author":[{"given":"Bogdan","family":"Jakiela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Soja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Sladek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Przybyszowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Plutecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gielicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rebane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2455-7041","authenticated-orcid":false,"given":"Grazyna","family":"Bochenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.08.007_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.08.007_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1183\/09031936.03.00261903","article-title":"The ENFUMOSA cross-sectional European multicenter study of the clinical phenotype of chronic severe asthma","volume":"22","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.08.007_bib4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2005.08.035","article-title":"Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult to treat asthma","volume":"116","author":"Mascia","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1034\/j.1398-9995.2002.13508.x","article-title":"Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity","volume":"57","author":"Kowalski","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.08.007_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.08.007_bib7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/path.1979","article-title":"Expression\u00a0of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal\u00a0polyps of patients with aspirin-intolerant asthma","volume":"209","author":"Adamjee","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.jaci.2020.08.007_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib9","doi-asserted-by":"crossref","first-page":"15858","DOI":"10.1073\/pnas.0707413104","article-title":"Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids","volume":"104","author":"Woodruff","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaci.2020.08.007_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib11","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/ajrccm.156.5.9702072","article-title":"Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in aspirin-sensitive and non-aspirin-sensitive asthmatics airways","volume":"156","author":"Sousa","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2016.11.023","article-title":"Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease","volume":"140","author":"Eastman","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib15","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/cea.12654","article-title":"Induced sputum supernatant bioactive lipid mediators can identify subtypes of asthma","volume":"45","author":"Mastalerz","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.08.007_bib16","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/all.13075","article-title":"Identification of phenotypic clusters of non-steroidal anti-inflammatory drugs exacerbated respiratory disease","volume":"72","author":"Lee","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.08.007_bib17","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib19","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jaci.2016.08.048","article-title":"U-BIOPRED clinical asthma clusters linked to a subset of sputum omics","volume":"139","author":"Lefaudeux","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0037-1606217","article-title":"Airway inflammation and inflammatory biomarkers","volume":"39","author":"Lim","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib21","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jaci.2010.12.1108","article-title":"Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype","volume":"127","author":"Sanak","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1183\/09031936.00112306","article-title":"Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults","volume":"30","author":"Balbi","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.08.007_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1183\/09031936.00.15110900","article-title":"Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD","volume":"15","author":"Rutgers","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.08.007_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2249.2011.04529.x","article-title":"Bronchoalveolar lavage cell pattern from healthy human lung","volume":"167","author":"Heron","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/rr83","article-title":"Small airway inflammation in asthma","volume":"2","author":"Tulic","year":"2001","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2020.08.007_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1183\/09031936.04.00063003","article-title":"Safety of research bronchoscopy, biopsy and bronchoalveolar lavage in asthma","volume":"24","author":"Elston","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.08.007_bib27","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1164\/ajrccm.152.6.8520757","article-title":"Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage","volume":"152","author":"Maestrelli","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1365-2222.1997.890900.x","article-title":"Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies","volume":"27","author":"Grootendorst","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.08.007_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1164\/ajrccm.152.1.7599862","article-title":"Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects","volume":"152","author":"Fahy","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1183\/09031936.98.12030595","article-title":"Leukocyte counts and macrophage phenotypes in induced sputum and bronchoalveolar lavage fluid from normal subjects","volume":"12","author":"Lensmar","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.08.007_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-017-0511-6","article-title":"Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function","volume":"17","author":"Brooks","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1081-1206(10)62815-3","article-title":"Immunohistochemical characterization of cellular infiltrate in nasal polyp from aspirin-sensitive asthmatic patients","volume":"81","author":"Park","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1034\/j.1399-3003.1999.14c21.x","article-title":"Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis","volume":"14","author":"Varga","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2020.08.007_bib34","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/lary.21969","article-title":"Evidence for distinct histologic profile of nasal polyps with and without eosinophilia","volume":"121","author":"Payne","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2020.08.007_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/ajrccm.153.1.8542168","article-title":"Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects","volume":"153","author":"Nasser","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib36","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1164\/ajrccm.154.6.8970343","article-title":"Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics","volume":"154","author":"Szczeklik","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib37","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/ajrccm.149.4.8143059","article-title":"Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge","volume":"149","author":"Sladek","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib38","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/thx.2008.101196","article-title":"Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma","volume":"63","author":"Gaber","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2020.08.007_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000331433","article-title":"Challenge of isolated sputum cells supports in\u00a0vivo origin of intolerance reaction to aspirin\/non-steroidal anti-inflammatory drugs in asthma","volume":"158","author":"Higashi","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1301753","article-title":"Aspirin activation of eosinophils and mast cells: implications in the pathogenesis ofaspirin-exacerbated respiratory disease","volume":"193","author":"Steinke","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1164\/rccm.201510-2032PP","article-title":"Roles of periostin in respiratory disorders","volume":"193","author":"Izuhara","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.08.007_bib42","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.4049\/jimmunol.1701455","article-title":"Elevated expression of IL-33 and TSLP in the airways of human asthmatics in\u00a0vivo: a potential biomarker of severe refractory disease","volume":"200","author":"Li","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaip.2018.08.024","article-title":"Children with neutrophil-predominant severe asthma have proinflammatory neutrophils with enhanced survival and impaired clearance","volume":"7","author":"Grunwell","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.08.007_bib44","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaci.2019.08.039","article-title":"IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation","volume":"144","author":"Allinne","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2332\/allergolint.11-OA-0370","article-title":"Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis","volume":"61","author":"Ishida","year":"2012","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2020.08.007_bib46","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.21037\/jtd.2018.11.12","article-title":"Excessive periostin expression and Th2 response in patients with nasal polyps: association with asthma","volume":"10","author":"Wei","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jaci.2020.08.007_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2006.02.046","article-title":"Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals","volume":"118","author":"Takayama","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.20452\/pamw.3299","article-title":"Comparative study of periostin expression indifferent respiratory samples in patients with asthma and chronic obstructive pulmonary disease","volume":"126","author":"G\u00f3rska","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.jaci.2020.08.007_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaci.2012.06.025","article-title":"Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients","volume":"130","author":"Jia","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.08.007_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thoraxjnl-2014-205634","article-title":"External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma","volume":"70","author":"Wagener","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2020.08.007_bib51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2014.06.014","article-title":"Association of serum periostin with aspirin-exacerbated respiratory disease","volume":"113","author":"Kim","year":"2014","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920311350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920311350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:32:31Z","timestamp":1758792751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920311350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0091674920311350"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.08.007","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}